Considering Immuno-autonomics in Stratifying Successful Treatment of Rheumatoid Arthritis with Tumor Necrosis Factor Inhibition: Comment on Cohen et al. Rheumatol Ther 2021 June 19
Crossref DOI link: https://doi.org/10.1007/s40744-021-00386-w
Published Online: 2021-11-10
Published Print: 2022-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Holman, Andrew J.
Keystone, Edward
Choy, Ernest
Furst, Daniel
Taylor, Peter
Gaylis, Norman
Text and Data Mining valid from 2021-11-10
Version of Record valid from 2021-11-10
Article History
Received: 6 August 2021
Accepted: 12 October 2021
First Online: 10 November 2021